Huya Bioscience International
United States of America
Dr. Mireille Gillings is the CEO and Executive Chair of HUYA Bioscience International, the privately held global leader in accelerating development of biopharma innovation originating in China. As a visionary leader with more than 28 years’ experience in the biotech sector, Dr. Gillings has a unique balance of scientific and operational experience, including neurological and neurodegenerative disease research, preclinical and clinical study design, drug development, academic partnering programs and extensive business leadership skills. For more than a decade, Dr. Gillings has been a pioneer in collaborating with Chinese academic and commercial organizations to improve public health and create value in worldwide markets for China-sourced biopharma compounds. Dr. Gillings has been the driving force in building HUYA to its current position of strength. HUYA’s network of scouts has yielded the industry’s largest database of China-sourced molecules.